Search
Menu
Zurich Instruments AG - Boost Your Optics 1-24 LB

Mauna Kea Miniprobe Receives FDA Clearance

Facebook X LinkedIn Email
PARIS, June 2, 2016 — Microscopy developer Mauna Kea Technologies SA has received its twelfth 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The new FDA clearance covers its confocal miniprobes for use in urological and minimally invasive surgical applications with its NIR (near-infrared) Cellvizio platform. The company said its NIR imaging products are designed to provide a positive impact on procedural outcomes by adding the precision and reliability of real-time cellular characterization to fluorescence-guided procedures.

Mauna Kea is a global medical device company focused on the diagnosis and treatment of cancer through in vivo microscopic visualization.
CASTECH INC - High Precision CNC Polished Aspherical Lenses

Published: June 2016
BusinessEuropeFranceBiophotonicsMauna KeaImagingFDAdistributionconfocal miniprobeurologyCellvizioNIR

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.